NovaBridge Biosciences Cost of Revenue
NovaBridge Biosciences (NBP) reported Cost of Revenue of CNY 27.24 million for the 12-month period ending 2022-12-31, per its 20-F filed 2024-04-30.
Discontinued › Expense Statement
us-gaap:CostOfRevenue · last filed 2024-04-30
CNY
| Period end | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|
| 2022-12-31 | 27.24M CNY 20-F · filed 2024-04-30 | |
| 2022-06-30 | 27.24M CNY 6-K · filed 2022-11-10 | |
| 2021-12-31 | 46.43M CNY 20-F · filed 2024-04-30 | |
| 2020-12-31 | 0.00 CNY 20-F · filed 2022-04-29 | |
| 2019-12-31 | 0.00 CNY 20-F · filed 2022-04-29 |
USD
| Period end | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|
| 2022-12-31 | $3.95M 20-F · filed 2023-05-01 | |
| 2022-06-30 | $4.07M 6-K · filed 2022-11-10 | |
| 2021-12-31 | $7.29M 20-F · filed 2022-04-29 |